Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voclosporin versus placebo for active noninfectious intermediate/posterior uveitis
NL-OMON36584Phase 3Withdrawn
- Sponsor
- Lux Biosciences, Inc.
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in uveitis, Hyalitis, posterior uveitis and 1 more comparing Voclosporin with Placebo (2 arms). Primary endpoint: Change from baseline in graded vitreous haze. Planned start Jan 2011; status: withdrawn.
02
Drugs
voclosporin
03
Conditions
uveitisHyalitisposterior uveitispanuveitis
Beyond the preview
Go deeper on NL-OMON36584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36584.